Enteropathy-associated T-cell lymphoma: Difference between revisions
No edit summary |
Nima Nasiri (talk | contribs) No edit summary |
||
Line 5: | Line 5: | ||
{{Enteropathy-associated T-cell lymphoma}} | {{Enteropathy-associated T-cell lymphoma}} | ||
{{CMG}}; {{AE}} {{Nnasiri | {{CMG}}; {{AE}} {{Nnasiri}} | ||
{{SK}} Enteropathy-type T-cell lymphoma; Intestinal T-cell lymphoma; EATL; ETTL | {{SK}} Enteropathy-type T-cell lymphoma; Intestinal T-cell lymphoma; EATL; ETTL |
Latest revision as of 17:25, 6 March 2019
For patient information, click here
Enteropathy-associated T-cell lymphoma Microchapters |
Differentiating Enteropathy-associated T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Enteropathy-associated T-cell lymphoma On the Web |
American Roentgen Ray Society Images of Enteropathy-associated T-cell lymphoma |
Risk calculators and risk factors for Enteropathy-associated T-cell lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]
Synonyms and keywords: Enteropathy-type T-cell lymphoma; Intestinal T-cell lymphoma; EATL; ETTL
Overview
Historical perspective
Classification
Pathophysiology
Causes
Differentiating Enteropathy-associated T-cell lymphoma from Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnostic criteria
Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies